A Third Shot at EGFR: New Opportunities in Cancer Therapy-Reference-Cited by-同舟云学术

A Third Shot at EGFR: New Opportunities in Cancer Therapy

Published:2019-12 Issue:12 Volume:40 Page:941-955
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Guardiola Salvador,Varese Monica,Sánchez-Navarro Macarena,Giralt Ernest

Funder

MINECO-FEDER

Generalitat de Catalunya

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference122 articles.

1. The EGFR family: not so prototypical receptor tyrosine kinases;Lemmon;Cold Spring Harb. Perspect. Biol.,2014

2. EGF–ERBB signalling: towards the systems level;Citri;Nat. Rev. Mol. Cell Biol.,2006

4. Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence;Troiani;ESMO Open,2016

5. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression;Ohsaki;Oncol. Rep.,2000

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Cytotoxicity and Metabolic Profiling of Synechocystis sp. Extract Encapsulated in Nano-Liposomes and Nano-Niosomes Using LC-MS, Complemented by Molecular Docking Studies;Biology;2024-07-31

2. Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data;Frontiers in Pharmacology;2024-07-25

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. Crosstalk of growth factor receptors at plasma membrane clathrin-coated sites;2024-05-18

5. Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach;ACS Omega;2024-03-25